Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bartenstein

Showing results (481-490 of 546) with videos related to

Pageof 55
Sort By:
The Lancet. Neurology|February 5, 2013
Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trialRichard Dodel, Axel Rominger, Peter Bartenstein, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 30, 2021
Dosimetry and optimal scan time of [<sup>18</sup>F]SiTATE-PET/CT in patients with neuroendocrine tumoursLeonie Beyer, Astrid Gosewisch, Simon Lindner, et al.
Cancers|November 19, 2020
Outcome After 68Ga-PSMA-11 versus Choline PET-Based Salvage Radiotherapy in Patients with Biochemical Recurrence of Prostate Cancer: A Matched-Pair AnalysisNina-Sophie Schmidt Hegemann, Paul Rogowski, Chukwuka Eze, et al.
Frontiers in Oncology|May 27, 2021
Combining <sup>68</sup>Ga-PSMA-PET/CT-Directed and Elective Radiation Therapy Improves Outcome in Oligorecurrent Prostate Cancer: A Retrospective Multicenter StudySimon Kirste, Stephanie G C Kroeze, Christoph Henkenberens, et al.
Journal of Medicinal Chemistry|December 20, 2017
Identification of [<sup>18</sup>F]TRACK, a Fluorine-18-Labeled Tropomyosin Receptor Kinase (Trk) Inhibitor for PET ImagingVadim Bernard-Gauthier, Andrew V Mossine, Anne Mahringer, et al.
Frontiers in Medicine|November 3, 2022
18 kDa translocator protein positron emission tomography facilitates early and robust tumor detection in the immunocompetent SB28 glioblastoma mouse modelLaura M Bartos, Sabrina V Kirchleitner, Jens Blobner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 29, 2023
Correction to: Next‑generation PET/CT imaging in meningioma-first clinical experiences using the novel SSTR‑targeting peptide [<sup>18</sup>F]SiTATEMarcus Unterrainer, Sophie C Kunte, Lena M Unterrainer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 4, 2024
Improved Tau PET SUVR Quantification in 4-Repeat Tau Phenotypes with [<sup>18</sup>F]PI-2620Gérard N Bischof, Matthias Brendel, Henryk Barthel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 26, 2023
Next-generation PET/CT imaging in meningioma-first clinical experiences using the novel SSTR-targeting peptide [<sup>18</sup>F]SiTATEMarcus Unterrainer, Sophie C Kunte, Lena M Unterrainer, et al.
Brain : a Journal of Neurology|March 23, 2021
TSPO PET imaging of natalizumab-associated progressive multifocal leukoencephalopathyChristoph Mahler, Adrian-Minh Schumacher, Marcus Unterrainer, et al.
Pageof 55

Showing results (481-490 of 546) with videos related to

Sort By:
Pageof 55
The Lancet. Neurology|February 5, 2013
Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trialRichard Dodel, Axel Rominger, Peter Bartenstein, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 30, 2021
Dosimetry and optimal scan time of [<sup>18</sup>F]SiTATE-PET/CT in patients with neuroendocrine tumoursLeonie Beyer, Astrid Gosewisch, Simon Lindner, et al.
Cancers|November 19, 2020
Outcome After 68Ga-PSMA-11 versus Choline PET-Based Salvage Radiotherapy in Patients with Biochemical Recurrence of Prostate Cancer: A Matched-Pair AnalysisNina-Sophie Schmidt Hegemann, Paul Rogowski, Chukwuka Eze, et al.
Frontiers in Oncology|May 27, 2021
Combining <sup>68</sup>Ga-PSMA-PET/CT-Directed and Elective Radiation Therapy Improves Outcome in Oligorecurrent Prostate Cancer: A Retrospective Multicenter StudySimon Kirste, Stephanie G C Kroeze, Christoph Henkenberens, et al.
Journal of Medicinal Chemistry|December 20, 2017
Identification of [<sup>18</sup>F]TRACK, a Fluorine-18-Labeled Tropomyosin Receptor Kinase (Trk) Inhibitor for PET ImagingVadim Bernard-Gauthier, Andrew V Mossine, Anne Mahringer, et al.
Frontiers in Medicine|November 3, 2022
18 kDa translocator protein positron emission tomography facilitates early and robust tumor detection in the immunocompetent SB28 glioblastoma mouse modelLaura M Bartos, Sabrina V Kirchleitner, Jens Blobner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 29, 2023
Correction to: Next‑generation PET/CT imaging in meningioma-first clinical experiences using the novel SSTR‑targeting peptide [<sup>18</sup>F]SiTATEMarcus Unterrainer, Sophie C Kunte, Lena M Unterrainer, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 4, 2024
Improved Tau PET SUVR Quantification in 4-Repeat Tau Phenotypes with [<sup>18</sup>F]PI-2620Gérard N Bischof, Matthias Brendel, Henryk Barthel, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 26, 2023
Next-generation PET/CT imaging in meningioma-first clinical experiences using the novel SSTR-targeting peptide [<sup>18</sup>F]SiTATEMarcus Unterrainer, Sophie C Kunte, Lena M Unterrainer, et al.
Brain : a Journal of Neurology|March 23, 2021
TSPO PET imaging of natalizumab-associated progressive multifocal leukoencephalopathyChristoph Mahler, Adrian-Minh Schumacher, Marcus Unterrainer, et al.
Pageof 55